The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years.

OBJECTIVE It is hypothesized that the systemic inflammation associated with rheumatoid arthritis (RA) promotes an increased risk of cardiovascular (CV) morbidity and mortality. We examined the risk and determinants of congestive heart failure (CHF) in patients with RA. METHODS We assembled a population-based, retrospective incidence cohort from among all individuals living in Rochester, Minnesota, in whom RA (defined according to the American College of Rheumatology 1987 criteria) was first diagnosed between 1955 and 1995, and an age- and sex-matched non-RA cohort. After excluding patients in whom CHF occurred before the RA index date, all subjects were followed up until either death, incident CHF (defined according to the Framingham Heart Study criteria), migration from the county, or until January 1, 2001. Detailed information from the complete medical records (including all inpatient and outpatient care provided by all local providers) regarding RA, ischemic heart disease, and traditional CV risk factors was collected. Cox models were used to estimate the effect of RA on the development of CHF, adjusting for CV risk factors and/or ischemic heart disease. RESULTS The study population included 575 patients with RA and 583 subjects without RA. The CHF incidence rates were 1.99 and 1.16 cases per 100 person-years in patients with RA and in non-RA subjects, respectively (rate ratio 1.7, 95% confidence interval [95% CI] 1.3-2.1). After 30 years of followup, the cumulative incidence of CHF was 34.0% in patients with RA and 25.2% in non-RA subjects (P< 0.001). RA conferred a significant excess risk of CHF (hazard ratio [HR] 1.87, 95% CI 1.47-2.39) after adjusting for demographics, ischemic heart disease, and CV risk factors. The risk was higher among patients with RA who were rheumatoid factor (RF) positive (HR 2.59, 95% CI 1.95-3.43) than among those who were RF negative (HR 1.28, 95% CI 0.93-1.78). CONCLUSION Compared with persons without RA, patients with RA have twice the risk of developing CHF. This excess risk is not explained by traditional CV risk factors and/or clinical ischemic heart disease.

[1]  S. Gabriel,et al.  Cardiovascular death in rheumatoid arthritis: a population-based study. , 2005, Arthritis and rheumatism.

[2]  S. Gabriel,et al.  Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. , 2005, Arthritis and rheumatism.

[3]  A. Bell,et al.  D-penicillamine induced polymyositis causing complete heart block , 1994, Clinical Rheumatology.

[4]  B. Dijkmans,et al.  Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[5]  B. Yawn,et al.  Trends in heart failure incidence and survival in a community-based population. , 2004, JAMA.

[6]  A. A. Drosos,et al.  Epidemiology of rheumatoid arthritis. , 2004, Autoimmunity reviews.

[7]  F. Wolfe,et al.  Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. , 2004, The American journal of medicine.

[8]  B. Dijkmans,et al.  Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. , 2004, Arthritis and rheumatism.

[9]  A. Hoes,et al.  Classification of heart failure in population based research: An assessment of six heart failure scores , 1997, European Journal of Epidemiology.

[10]  H. Ugurlu,et al.  Ventricular function abnormalities in active rheumatoid arthritis: a Doppler echocardiographic study , 2004, Rheumatology International.

[11]  S. Rubin,et al.  Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study , 2003, Circulation.

[12]  Göran Hallmans,et al.  Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[13]  H. Ni.  Prevalence of self-reported heart failure among US adults: results from the 1999 National Health Interview Survey. , 2003, American heart journal.

[14]  H. Guess,et al.  All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. , 2003, The Journal of rheumatology.

[15]  D. Levy,et al.  Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction: The Framingham Heart Study , 2003, Circulation.

[16]  G. Freeman,et al.  Proinflammatory cytokines: predictors of a failing heart? , 2003, Circulation.

[17]  JoAnn E. Manson,et al.  Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis , 2003, Circulation.

[18]  S. Hernández-Díaz,et al.  Nonsteroidal Antiinflammatory Drugs as a Trigger of Clinical Heart Failure , 2003, Epidemiology.

[19]  S. Gabriel,et al.  Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. , 2003, Arthritis and rheumatism.

[20]  F. Wolfe,et al.  Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. , 2003, The Journal of rheumatology.

[21]  A. Silman,et al.  Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. , 2002, Arthritis and rheumatism.

[22]  V. Roger,et al.  Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979–1994 ☆ , 2002 .

[23]  James M Robins,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[24]  B. Yawn,et al.  Trends in the Incidence and Survival of Patients with Hospitalized Myocardial Infarction, Olmsted County, Minnesota, 1979 to 1994 , 2002, Annals of Internal Medicine.

[25]  S. Gabriel,et al.  Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. , 2002, The Journal of rheumatology.

[26]  Pål Aukrust,et al.  Cytokines as new treatment targets in chronic heart failure , 2001, Current controlled trials in cardiovascular medicine.

[27]  M. Ward,et al.  Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs? , 2001, Arthritis and rheumatism.

[28]  P. Whelton,et al.  Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. , 2001, Archives of internal medicine.

[29]  G. Kitas,et al.  Cardiac involvement in rheumatoid disease. , 2001, Clinical medicine.

[30]  H. Miller,et al.  Pathophysiological role of cytokines in congestive heart failure. , 2001, Annual review of medicine.

[31]  S G Thompson,et al.  Survival of patients with a new diagnosis of heart failure: a population based study , 2000, Heart.

[32]  D. Henry,et al.  Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. , 2000, Archives of internal medicine.

[33]  G. Labbadia,et al.  Diastolic function abnormalities in rheumatoid arthritis. Evaluation by echo Doppler transmitral flow and pulmonary venous flow: relation with duration of disease , 2000, Annals of the rheumatic diseases.

[34]  S. Rantapää-Dahlqvist,et al.  Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. , 1999, The Journal of rheumatology.

[35]  W M O'Fallon,et al.  Comorbidity in arthritis. , 1999, The Journal of rheumatology.

[36]  R. Caporali,et al.  Impaired diastolic function in active rheumatoid arthritis. Relationship with disease duration. , 1999, Clinical and experimental rheumatology.

[37]  J Crowley,et al.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.

[38]  S. Gabriel,et al.  The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. , 1999, Arthritis and rheumatism.

[39]  F. Tremel,et al.  Chloroquine cardiomyopathy with conduction disorders , 1999, Heart.

[40]  P. Hannonen,et al.  Mortality in early "sawtooth" treated rheumatoid arthritis patients during the first 8-14 years. , 1999, Scandinavian journal of rheumatology.

[41]  M. Wislowska,et al.  Echocardiographic findings and 24-h electrocardiographic Holter monitoring in patients with nodular and non-nodular rheumatoid arthritis , 1999, Rheumatology International.

[42]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[43]  Claude Bouchard,et al.  Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary , 1998 .

[44]  J. Heikkilä,et al.  Congestive heart failure in old age: prevalence, mechanisms and 4‐year prognosis in the Helsinki Ageing Study , 1997, Journal of internal medicine.

[45]  S. R. Dahlqvist,et al.  Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. , 1997, The Journal of rheumatology.

[46]  Detection.  The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .

[47]  L. Melton,et al.  History of the Rochester Epidemiology Project. , 1996, Mayo Clinic proceedings.

[48]  G. Alarcón,et al.  Survival and drug discontinuation analyses in a large cohort of methotrexate treated rheumatoid arthritis patients. , 1995, Annals of the rheumatic diseases.

[49]  H. Kautiainen,et al.  Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis. , 1995, Clinical and experimental rheumatology.

[50]  K. Bailey,et al.  The incidence and prevalence of congestive heart failure in Rochester, Minnesota. , 1993, Mayo Clinic proceedings.

[51]  D. Levy,et al.  The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.

[52]  S. Pillemer,et al.  Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians. , 1993, Arthritis and rheumatism.

[53]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[54]  M. Laakso,et al.  Cardiovascular mortality in patients with rheumatoid arthritis. , 1989, Cardiology.

[55]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[56]  J. Myles,et al.  Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy. , 1987, The New England journal of medicine.

[57]  R J Prineas,et al.  International diagnostic criteria for acute myocardial infarction and acute stroke. , 1984, American heart journal.

[58]  Ronald J. Prineas,et al.  The Minnesota code manual of electrocardiographic findings : standards and procedures for measurement and classification , 1982 .

[59]  L. Kurland,et al.  The patient record in epidemiology. , 1981, Scientific American.

[60]  David R. Cox,et al.  SOME SIMPLE APPROXIMATE TESTS FOR POISSON VARIATES , 1953 .